Small Pox and Anthrax Frights Planned Before 911

Government and Drug Industry Collusion Cited
 
Sandpoint, ID —There’s more to the current smallpox fright than meets the eye according to public health authority, Dr. Leonard Horowitz. Cipro, anthrax vaccine, and the current smallpox vaccine “sales campaigns” were planned years before the 9-11 terrorist attacks on America. The only realistic explanation, he argues, involves government and drug industry collusion.

            The parent companies that produce these favored elixirs for anthrax and smallpox bioterrorism are linked, strangely enough, to an infamous history involving contaminated blood, the Central Intelligence Agency (CIA), and even the Nazis of World War II, according to the research findings of this Harvard graduate and independent investigator. These historic, well documented, associations Dr. Horowitz says, seem to be tabooed subject matter for even the F.B.I. whose investigators he hounded for six months before they finally consulted with him regarding the mysterious anthrax mailings. The doctor’s warning to the bureau regarding a developing “anthrax scam” came one week before the first mailings were announced by the press.

            CIPRO, Dr. Horowitz recalls, is produced by Germany’s Bayer AG, while the smallpox vaccine’s newly formed producer is the British firm Acambis (previously OraVax), owned by Aventis—created in 1999 by parent companies Hoechst and Rhone-Poulenc. The Merck pharmaceutical company, recipient of a large share of the Nazi war chest at the end of WWII, is are partnered with these entitites in Europe and thus involved in the smallpox and West Nile Virus vaccine trade. The only other smallpox and West Nile Virus vaccine producer is Baxter Corporation, a subsidiary of American Home Products—another direct progeny of the decartelized German drug and chemical combine known as I.G. Farben. All have jaded, if not blatant genocidal, histories.

            Bayer, Baxter, and Rhone-Poulenc are infamously known for having infected more than 7,000 American hemophiliacs with the AIDS virus during the early 1980s. They admitted foreknowledge in selling HIV-tainted blood clotting products and settled the class action case for $100,000 per claimant.(1)

            Bayer and Hoechst were formed following World War II from the “decartelization” of Germany’s leading industrial organization and Nazi economic engine—I.G. Farben. The CIA immediately took over their vacated corporate headquarters which had curiously escaped allied bombings. Historians explain that the Farben complex had been protected by officials of John D. Rockefeller’s Standard Oil Company—half owner of the Farben cartel. Many believe that Rockefeller lawyer and Standard Oil business manager, Allen Dulles, among the CIA’s first directors, military-command-protected Farben headquarters from allied bombings. In the current age when past CIA Director James Woolsey lectures on “industrial espionage” as a primary function of modern intelligence organizations, this history portends serious ramifications, particularly in-so-far-as America’s “New War on Terrorism” is concerned.

            Soon after the CIA formed, Bayer and Hoechst were reorganized in 1951 under the direction of the Allied High Commission, largely influenced by U.S. High Commissioner John J. McCloy—a lawyer and banker from Philadelphia, with intimate ties to Rockefeller banking and oil interests. After “decartelization,” the I.G. Farben plants, including all the labor camps involved in the mostly Jewish genocide were consolidated into three main holding companies: Bayer, Hoechst, and BASF for the benefit of all the stockholders.

            Hermann Schmitz, president of Bayer A.G and I.G. Farben during WWII,  who also largely directed the Deutsche Bank,  “held as much stock in Standard Oil of New Jersey as did the Rockefellers,” according to former CBS News war correspondent Paul Manning. Acknowledging CIA director Dulles for his information, Manning reported that on August 10, 1944, the Rockefeller-Farben partners moved their “flight capital” through affiliated German/French, American, British and Swiss banks “for the new Germany.” This secured “the sophisticated distribution of national and corporate assets to safe havens” throughout the world, and assured the continuation and further development of the “Neuordnung” (new order or “New World Order”) for both the global petrochemical pharmaceutical industry and banking cartels.(2)

            More recent revelations exposing the Bush family’s involvement in this Euro-American conspiracy, and war economy profiteering, were advanced by John Loftus, a former U.S. Department of Justice Nazi War Crimes prosecutor, and the President of the Florida Holocaust Museum. Attorney Loftus is also the co-author of The Secret War Against the Jews, and has published extensively on the Bush-Rockefeller-Nazi political and economic connections. Quoting from Loftus:

The Bushes knew perfectly well that Brown Brothers was the American money channel into Nazi Germany, and that Union Bank was the secret pipeline to bring the Nazi money back to America from Holland. The Bushes had to have known how the secret money circuit worked because they were on the board of directors in both directions: Brown Brothers out, Union Bank in. . . Moreover, the size of their compensation [was] commensurate with their risk as Nazi money launderers. . . The bottom line is harsh: It is bad enough that the Bush family helped raise the money for [Fritz] Thyssen [arguably Germany’s wealthiest industrialist] to give Hitler his start in the 1920's, but giving aid and comfort to the enemy in time of war is treason.” (For Loftus’s complete report go to: smallpoxandanthrax)
           
            Given this generally unknown history, is it surprising that Bush administration Secretary of the Department of Health and Human Services (HHS), Tommy Thompson, and other Bush cabinet members met secretly (that is, illegally) with officials of the Pharmaceutical Research and Manufacturers of America (PhRMA) to develop plans for their Emergency Preparedness Task Force? The group is said to have prepared enough drugs and vaccines to protect every American against the threats of anthrax and smallpox. PhRMA task force officials, directed by Aventis executive Richard Markham, and representing a number of other Farben-Rockefeller progeny and beneficiaries including American Home Products, Abbott Laboratories, Merck, Pfizer, and more, according to the New York Times (Nov. 4, 2001), have met regularly with Bush cabinet members. According to Dr. Sidney M. Wolfe, a director at Ralph Nader’s public Citizen Health Research Group, the meetings violated a federal law for transparency of such decision-making committees.(3)

            Apparent illegalities did not deter Secretary Thompson from ordering more than $100 million worth of CIRPO from Bayer at the “bargain price” of $.90 per tablet, when other companies offered equally effective and lower risk substitutes for a few pennies each, and then for free. No one ever questioned the unprecedented FDA selection of this single, largely untested, extraordinarily expensive, antibiotic called CIPRO for anthrax. Incredibly, according to the Physician’s Desk Reference and American Medical Association, the drug is contraindicated for conditions resulting in pneumonia, which is how anthrax kills. The end result of this “scam” was predictable. By January 2002, after more than 32,000 people in Metropolis (i.e., Washington to Boston) consumed CIPRO in the wake of the anthrax mailings, thousands had become seriously ill, many died, as a result. This death toll has never been counted in assessing the damage brought about by the mailings.

            On October 25, 2001, health czar Thompson also asked Congress for another $500 million to order enough of Acambis’s smallpox vaccine “so every American will be assured there is a dose with his or her name on it if it is needed,” even though CDC officials admitted that people already vaccinated probably be revaccinated, and the new remedy would require extensive testing.(4,5)

            CDC officials met on June 8, 2002 to discuss the ramifications of mass smallpox vaccinations. At this meeting in St. Louis, Dr. Joel Kuritsy, the CDC’s director of Preparedness and Early Smallpox Response Activity, stated that “smallpox is not explosively contagious,” and not suited for use as a biological weapon since its person-to-person spread depends on “droplet contamination.” Since “coughing and sneezing are not part of the disease,” he noted, the disease is “transmitted slowly and only after prolonged, direct, face-to-face contact.” He additionally clarified “prolonged contact” to mean “more than 7 days,” and “face-to-face” to mean “contact that is within 6-7 feet.”(6)

            “The scenario in which a terrorist infects himself and walks through a city spreading the disease just wouldn’t happen, even in population-dense areas,” Dr. Kuritsky explained. “In the 1970s, we were able to control the spread of the infection even in highly dense settings such as India and Bangladesh,” using standard means of prevention and treatment other than mass smallpox vaccination. In fact, experts have unanimously cited isolation, ideally in the comfort of one’s own home under care by family members who use standard infection control (OSHA) methods and materials (such as safe waste disposal, gloves and masks, and surface disinfectants) as the best way to arrest a smallpox outbreak. One would never know this according to the media propaganda surrounding the smallpox and anthrax frights.(6)

            On September 24, 2002, the day the Bush administration announced its national smallpox vaccination plan, William Broad of the New York Times covered the drawbacks of this operational program. “The new guidelines for states on mass smallpox vaccinations are most notable for what was omitted,” he wrote. Omissions included “unanswered and often unaddressed questions like timing, costs, feasibility and multiple problems of preparing health care workers to conduct vaccinations, [and] communicating the plans to the public.” Broad neglected to mention the varied and even severe side effects of smallpox vaccination—another taboo subject. Apparently, the Bush administration, with its secreted links to the pharmaceutical industry, feels that they can simply neglect the experimental and risky nature of smallpox vaccinations by requiring “informed consent” statements be signed by recipients. This, of course, places the burden(s) of harmful, and even fatal, outcomes entirely on the shoulders its victims—the mass vaccinated American public.(7)      

            Meanwhile, smallpox vaccine maker Acambis’s sudden suspicious evolution from OraVax Corporation has left few suitably outraged.(8) The OraVax firm had been likewise  linked to shady backroom dealings with Clinton administration officials in 1998 regarding government orders for a yet to be tested West Nile Virus vaccine. Dr. Horowitz provided extensive details in this regard in Death in the Air: Globalism, Terrorism and Toxic Warfare (Tetrahedron Publishing Group; 1-888-508-4787). His prophetically-titled book was published three months before the 9-11 terrorist attacks. The text explained that the West Nile virus and smallpox vaccine deals evolved from a stealth meeting between Dr. Thomas Monath, the Vice President of OraVax (now Acambis/Aventis), President Clinton, Janet Reno, CIA Director John Deutsch, and American Type Culture Collection (ATCC) curator Dr. Joshua Lederberg, a former Rockefeller University President and Council on Foreign Relations (CFR) bioterrorism study group leader. The CFR is well known to be among the most politically influential organizations in America, if not he world.(9)

            According to the U.S. Congressional Record, the “official meeting” to discuss what had already been predetermined regarding the government’s nearly half-billion dollar smallpox, anthrax, and West Nile virus vaccine purchases took place before a joint meeting of the Senate Veterans Affairs Committee and the Subcommittee on Labor, Health and Human Services, Education, and Related Agencies of the Senate Appropriations Committee, on March 16, 1999. Here, the sole American anthrax vaccine maker—British-owned BioPort Corporation—sent representation in the person of scientific director, Dr. Robert C. Myers. The vaccine industrialist, referencing his work with the Battelle Memorial Institute—the CIA contractor for project “Clearvision” under which the hyper-concentrated anthrax weapon that was later mailed was initially developed—testified concerning the urgent need to stockpile both the anthrax and smallpox vaccines. Given the earlier official assessment of smallpox’s less than optimal use as a biological weapon, Myer’s precise manipulative words to senators included:

 BioPort manufactures the only FDA-licensed anthrax vaccine in the world. We are also making and testing vaccine . . . to protect against five different types of botulism, . . . It is probably next on the threat list behind anthrax and the rapidly emerging threat of smallpox. . . . [B]ecause smallpox is highly contagious and probably most of the world is now susceptible, it is a potential biowarfare agent of serious concern. . . . There exist similar challenges to the further development and manufacture of new vaccines for anthrax, smallpox, and, for that matter, any other biodefense vaccine. . . . Suppose we have a smallpox vaccine stockpile and a manufacturing capability. Suppose a terrorist group has smallpox as a weapon. . . . there should be two or more geographically separate manufacturing facilities and two or more facilities for storage of the manufactured vaccine.(10)
 
            It might be asked, how Dr. Myer’s derived his assessment that smallpox was a “rapidly emerging threat?” The fact is, smallpox had been eradicated from the planet decades ago. It was not officially considered a very good biological weapon as Dr. Kuritsky explained. It was widely known that the only remaining stores of smallpox were in Russian and American military–pharmaceutical labs. So aside from using a crystal ball, Dr. Myer’s statement implies he was privy, as an “inside trader/traitor” might be, to a conspiracy to either release the germ from these labs or simply create a fright in this regard. Suffice it to say, the current fright, predicted three years earlier by Dr. Myers and his vaccine industry cohorts, significantly influenced the purchase and rapid consumption of his company’s products.

            It should also be questioned, “Why, with more than two dozen potential biological weapons in the arsenals of the super-powers and “terrorist states,” would America be simply focused on two such threats—anthrax and smallpox?”

            For any intelligent rational person, if this smells like a skunk, it is most likely a skunk. This entire smallpox “scam” as Dr. Horowitz prefers to call it, represents a classic example of what he calls “white collar bioterrorism, reflecting on standard Machiavellian theory in practice. That is, inside traders create the problems for which they have already prepared profitable solutions.”

            Currently, what concerns Dr. Horowitz most is that these same dirty dealings and industrial powers are involved in the Bush administration’s justification to wage its ongoing war on terrorism, and invade Iraq later this Fall. Dr. Horowitz notes powerful Rockefeller interests represented by Dr. Lederberg’s presence among the inside traders who had met with Clinton administration officials in 1997. This Rockefeller and ATCC administrators had falsely assured the American public that no biological weapons were used during the Gulf War despite his knowledge that the ATCC, under his watch, sent nineteen shipments of various strains of anthrax, suitable for weapons production, to Saddam Hussein in the years leading up to Desert Storm. The U.S. Congress’ Don Reigle investigation concerning biological and chemical weapons used during the Gulf War exposed this fact. Their report cited the ATCC as commercially supplying Iraq with anthrax. Other biological weapons were shipped from the United States to Iraqi labs, including two shipments of the West Nile Virus in 1985.(11) So much for the accuracy in main stream media’s reporting of the sudden “first time” north American arrival of the West Nile Virus in 1999!

            Regarding last Fall’s anthrax mailings, in defense of the ATCC, its vice president, Nancy Wysocki, said, “We have a very close working relationship with many of the federal agencies, including the F.B.I.”(12) This might best explain why the FBI’s investigation of the anthrax mailings has stalled.

            Dr. Horowitz, in fact, hand delivered a memo to his regional F.B.I. office on October 1, 2001, almost two weeks before the first anthrax letter was sent from Trenton, New Jersey to the American media building in Boca Raton, Florida. His action was prompted by reading, The Final Report—the Oklahoma City bombing grand jury investigation commissioned study by then State Representative Charles Key. It stated that German-based neo-Nazi’s were known to have “masterminded” both airline hijackings and U.S. military installation bombings by the PLO. This matched what the F.B.I. reported, and what Dr. Horowitz knew about the German-based Bayer Corporation. The news reinforced his concerns about the Nazi-German connection to what was obviously a “CIPRO sales scam” linked to the anthrax mailings.(4)

            The F.B.I. also reported that the silica-mixed anthrax powder required expensive equipment, as well as a bioweapons savvy microbiologist, to produce. They had ruled out Islamic terrorist groups, but not “state-sponsored” crimes. This likewise suggested to Dr. Horowitz a “white collar” crime involving drug companies most likely to benefit from the mailings and ensuing fright.(12)

            Then the New York Times (November 11, 2001) reported that F.B.I. agents were denied access to “some pharmaceutical companies in New Jersey.” These ill-defined companies demanded “agents to present a subpoena before they would grant access to their files.”(12) Dr. Horowitz found this additionally suspicious, if not seriously incriminating, especially since smallpox vaccine maker Aventis, his primary suspect, had two plants within forty-five minutes drive from Trenton.

            “I should think that any company with nothing to hide would welcome the bureau’s inquiry especially at this time of dire national urgency,” Dr. Horowitz said. To him the drug firms’ response “exhibited a Gestapo-like attitude.”  

            “I’ve repeatedly asked the F.B.I. to thoroughly investigate the possibility of an industrial conspiracy in regard to this year’s threats of bioterrorism and mass vaccination. I’ve urged an inquiry into ATCC curator Dr. Joshua Lederberg, and the financial interests he represents, including Rockefeller pharmaceutical and banking interests,” Dr. Horowitz said. “According to every expert, terrorism is always conducted to express a political motive. When you consider the targets of the anthrax mailers—the mainstream media and two Democratic senators who have vigorously opposed the Bush administration’s appointements and big business efforts—a most plausible motive appears: frighten the public, along with legislators, to support a long-time-evolving agenda that includes drug and vaccine racketeering.”      
  
            “The trouble is,” Dr. Horowitz concluded, “Elliott Ness and dependable federal agents are long gone. This level of investigation may be impossible for the F.B.I. to adequately conduct, especially given the level of corruption and the Bush administration’s recent bureaucratic shuffle for heightened “homeland [in]security.”

            That is probably why Dr. Horowitz has made little headway in his efforts to direct the F.B.I. where he believes the evidence has suggested they go. “The president, and his highest level cabinet officials are implicated in this—a conspiracy that is most reasonably,” he said, “a deadly pharmaceutical sales scam.”



 
1) Massie RK. Blood feud: A mother takes the hemophilia tragedy to court. The New Yorker. June 16, 1997, p. 98.
2) Manning P. Martin Bormann: Nazi in Exile. Secaucus, NJ: Lyle Stuart, 1981, pp. 29, 56, 69, 116-17; 134-35.
3) Wolfe SM. Letter to HHS Secretary on Pharmaceutical Research & Manufacturers of America Emergency Preparedness Task Force (HRG Publication #1600). Public Citizen. Available at http://www.citizen.org/publications/release.cfm?ID=7101.
4) O’Meara KP. Investigative Report: Government ripoff on the Cipro deal. Washington Times, Insight Magazine, Nov. 26, 2001. Available at http://insightmag.com/main.cfm?include=detail&storyid=138294.
5) Charlotte D. Rules relaxed in rush for a new smallpox vaccine. The Guardian, Thursday, Oct. 25, 2001.
6) See: www.tetrahedron.org/articles/vaccine_awareness/CDC_Public_hearings_report.html
7) Broad WJ. Guide for mass smallpox vaccinations: recipe with missing ingredients. New York Times, September 24, 2002, P1. (See: http://www.nytimes.com/2002/09/24/national/24ASSE.html.
8) See: http://www.oravax.com/
9) Horowitz LG. Death in the Air: Globalism, Terrorism and Toxic Warfare. Tetrahedron Publishing Group, 2001, pp. 105-109.
10) Prepared Statement by Robert C. Myers, DVM, Chief Operating Officer and Director, BioPort Corporation, To a joint meeting of the Senate Veterans Affairs Committee and the Subcommittee on Labor, Health and Human Services, Education and Related Agencies of the Senate Appropriations Committee, March 16, 1999.
11) U.S. Senate, 103rd Congress, 2d Session. U.S. Chemical and Biological Warfare-related Dual Use Exports to Iraq and Their Possible Impact on the Health Consequences of the Persian Gulf War: A Report of Chairman Donald W. Riegle, Jr., et. al. May 25, 1994, pp. 39-47.
12) Broad WJ, Johnston D, Miller J and Zielbauer P. Experts see F.B.I. missteps hampering anthrax inquiry. New York Times, Nov. 9, 2001. Available at http://www.nytimes.com/2001/11/09/national/09INQU.html?todaysheadlines.




FAIR USE NOTICE: This site may contain copyrighted material, the use of which has not been specifically authorized by the copyright owner. This website distributes this material without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. We believe this constitutes a fair use of any such copyrighted material as provided for in 17 U.S.C § 107.

NOTE TO AUTHORS: If you are the author or owner of an article or video that I have made available through THEINFOVAULT.NET and you do not wish to have your article or video posted on theinfovault, please contact me and I will remove the item.